Clinical Trials Browser

Phase 2 × NETWORK × Melanoma × Clear all

NCT04221438 2026-05-12

Testing Treatment With Encorafenib and Binimetinib Before Surgery for Melanoma With Lymph Node Involvement

Phase 2 Terminated

3 enrolled 11 charts

Lymphatic Metastasis, Melanoma

NCT06623461 2026-05-12

Canbiome2

Phase 2 Recruiting

Melanoma

NCT04511013 2025-09-11

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

Phase 2 Recruiting

CNSDermatologic

Brain Neoplasms, Melanoma

NCT07130032 2025-08-19

reICB

Phase 2 Recruiting

DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma

NCT03235245 2025-08-01

EBIN

Phase 2 Active not recruiting

Melanoma

NCT07040280 2025-06-27

Testing the Effect of Sulforaphane, a Compound Naturally Found in Cruciferous Vegetables, on Preventing Melanoma in Patients With a Prior History of Melanoma

Phase 2 Not yet recruiting

Melanoma, Skin Neoplasms

NCT02740920 2023-08-25

Response to Pembrolizumab in Metastatic Melanoma: Computed Tomography Texture Analysis as a Predictive Biomarker

Phase 2 Terminated

9 enrolled 8 charts

Melanoma

NCT01152788 2023-08-22

Phase II Study of Interleukin-21 (rIL-21) vs Dacarbazine (DTIC) in Patients With Metastatic or Recurrent Melanoma

Phase 2 Completed

64 enrolled 10 charts

Melanoma

NCT00053781 2023-08-04

Perifosine in Treating Patients With Metastatic or Recurrent Malignant Melanoma

Phase 2 Completed

Melanoma

NCT00514085 2023-08-04

Interleukin-21 in Treating Patients With Metastatic or Recurrent Malignant Melanoma

Phase 2 Completed

Melanoma

NCT00700882 2023-07-03

Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery

Phase 2 Completed

81 enrolled 9 charts

Melanoma

NCT00049530 2023-06-29

PEG-Interferon Alfa-2b in Treating Patients With Stage IV Melanoma

Phase 2 Completed

32 enrolled 8 charts

Melanoma

NCT00071981 2023-06-28

Vaccine Therapy Using Melanoma Peptides for Cytotoxic T Cells and Helper T Cells in Treating Patients With Metastatic Melanoma

Phase 2 Completed

175 enrolled 12 charts

Melanoma

NCT00104884 2023-06-28

FR901228 in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma

Phase 2 Terminated

4 enrolled 4 charts

Melanoma

NCT00003308 2023-06-22

Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma

Phase 2 Completed

CNSDermatologicGenitourinaryGynecologicSarcoma

Brain Neoplasms, Carcinoma, Renal Cell, Chondrosarcoma, Kidney Neoplasms, Melanoma, Neoplasm Metastasis, Ovarian Neoplasms, Sarcoma, Osteosarcoma, Neuroectodermal Tumors, Primitive, Peripheral

NCT00003601 2023-06-18

Tretinoin With or Without Fenretinide in Treating Patients With Dysplastic Nevus Syndrome

Phase 2 Completed

Melanoma

NCT02974803 2021-08-20

Concurrent Dabrafenib + Trametinib With Sterotactic Radiation in BRAF Mutation-Positive Malignant Melanoma and Brain Metastases

Phase 2 Terminated

6 enrolled 3 charts

CNSDermatologic

Brain Neoplasms, Melanoma

NCT00005971 2020-04-09

Flavopiridol in Treating Patients With Metastatic Malignant Melanoma

Phase 2 Completed

Melanoma

NCT00086866 2015-02-10

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed With Surgery

Phase 2 Unknown

Melanoma

NCT00755976 2014-12-31

Sulindac and Epirubicin in Treating Patients With Metastatic Malignant Melanoma

Phase 2 Completed

Melanoma

NCT00526149 2013-10-07

BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors

Phase 2 Completed

BreastDermatologicGynecologicHead & NeckSarcoma

Malignant mesenchymal tumor, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Ovarian Epithelial, Breast Neoplasms, Fibrosarcoma, Head and Neck Neoplasms, Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Melanoma, Ovarian Neoplasms, Rhabdomyosarcoma, Sarcoma, Sarcoma, Synovial, Endometrial Neoplasms, Sarcoma, Endometrial Stromal, Sarcoma, Alveolar Soft Part, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous, Desmoplastic Small Round Cell Tumor

NCT00003911 2013-01-31

S9903: Whole Brain Radiotherapy Followed By Stereotactic Radiosurgery for Limited Malignant Melanoma Brain Metastases

Phase 2 Terminated

CNSDermatologic

Brain Neoplasms, Melanoma, Neoplasm Metastasis

NCT00003828 2012-08-22

S9804: Vinorelbine in Treating Patients With Stage IV Melanoma

Phase 2 Completed

Melanoma

NCT00104988 2012-08-22

S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery

Phase 2 Completed

Melanoma

NCT00014625 2012-07-24

E7070 in Treating Patients With Stage IV Melanoma

Phase 2 Completed

Melanoma

NCT00085059 2012-07-18

Boron Neutron Capture Therapy Using Boronophenylalanine-Fructose Complex in Treating Patients With Metastatic Melanoma

Phase 2 Terminated

Melanoma

NCT00003989 2012-07-11

ISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-small Cell Lung Cancer or Unresectable or Metastatic Melanoma

Phase 2 Completed

DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Melanoma

NCT00002669 2012-07-02

Combination Chemotherapy, Interferon Alfa, and Interleukin-2 in Treating Patients With Metastatic Melanoma

Phase 2 Completed

Melanoma

NCT00002860 2012-01-13

SWOG-9430: Surgery in Treating Patients With Metastatic Melanoma

Phase 2 Completed

Melanoma